NeuScience
San Antonio, Texas, United States
About NeuScience
NeuScience uses computer vision to detect phenotypic signals, resulting in a novel, pan-cancer biomarkers. The company's biological assay pairs the heterogeneity of patient tumor panels with the precision of single-cell phenotypic screening. NeuScience uses clinically-validated phenotypes and deep learning to discover novel single-cell biomarkers related to tumorigenesis, metastasis, toxicity, and drug resistance. The company was founded in 2018 by Guillermo Vela and Nicole Romano.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jan 2019)
- Website: neuscience.co
Industries & Categories
Biotechnology, Lifestyle
Social Profiles
Canonical: https://fsome.com/organization/neuscience-2249526 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.